Here, we found that the 4-gene ISR signature (DDIT3, GADD45B, CRYBA4, and HSPA1L) is strongly associated with poor prognosis in CRC patients, but also with sensitivity to BR in vitro and in vivo. Our model (Fig. 6j) helps explain this paradox. Here, CRYBA4 is linked to colorectal carcinoma.